Early Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography

Supriya Dabir,1 Mohan Rajan,1 Liji Parasseril,1 Vaidehi Bhatt,2 Preetam Samant,3 CAB Webers,4 TTJM Berendschot4 1Department of Retina, Rajan Eye Care Pvt Ltd, Chennai, India; 2Rajiv Gandhi Medical College, Thane, India; 3Department of Retina, PD Hinduja Hospital and Medical Research Center, Mumbai,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dabir S, Rajan M, Parasseril L, Bhatt V, Samant P, Webers C, Berendschot TTJM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/a089ed50f09e4a5489183b9ab9d6ad92
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a089ed50f09e4a5489183b9ab9d6ad92
record_format dspace
spelling oai:doaj.org-article:a089ed50f09e4a5489183b9ab9d6ad922021-12-02T14:08:53ZEarly Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography1177-5483https://doaj.org/article/a089ed50f09e4a5489183b9ab9d6ad922021-01-01T00:00:00Zhttps://www.dovepress.com/early-visual-functional-outcomes-and-morphological-responses-to-anti-v-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Supriya Dabir,1 Mohan Rajan,1 Liji Parasseril,1 Vaidehi Bhatt,2 Preetam Samant,3 CAB Webers,4 TTJM Berendschot4 1Department of Retina, Rajan Eye Care Pvt Ltd, Chennai, India; 2Rajiv Gandhi Medical College, Thane, India; 3Department of Retina, PD Hinduja Hospital and Medical Research Center, Mumbai, India; 4University Eye Clinic, Maastricht, the NetherlandsCorrespondence: Supriya DabirRajan Eye Care Hospital Pvt. Ltd, No. 5, Vidyodaya East 2nd Street, T. Nagar, Chennai, Tamil Nadu 600017, IndiaTel +919900974800Email supriad@gmail.comPurpose: Diabetic macular oedema (DME) is a vision-threatening complication of diabetic retinopathy. Spectral domain optical coherence tomography angiography (OCTA) is useful for assessing DME. We performed serial OCTA measurements before and after 3 monthly intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections to understand its relationship with best corrected visual acuity (BCVA), central macular thickness (CMT) and vascular indices.Methods: OCTA assessment consisting of 6 × 6 mm scans centred on fovea and en-face retinal angiograms were obtained. Scans were done at baseline and at 1 month following each of the 3 intravitreal injections of anti-VEGF (ranibizumab, Lucentis®).Results: Our prospective study included 24 eyes of 24 subjects, aged 63.0 ± 5.0 years. There was a mean gain of 0.07 LogMAR (3 letters) and reduction of CMT, vessel density (VD) and perfusion density (PD) by end of 3rd month. CMT was independently associated with improvement in BCVA. There were significant reductions in FAZ area, VD and PD over 3 months from baseline.Conclusion: At three months, intravitreal anti-VEGF therapy is associated with visual function recovery in DME, with reduction in CMT being the most reliable predictor of response. OCTA shows a reduction in VD and PD respectively suggestive of reduced macular perfusion in the short term. Simultaneous reduction in FAZ size can be due to reversal of manual displacement of the retinal capillaries resulting from resolution of intraretinal oedema.Keywords: diabetic macular oedema, superficial capillary plexus, vascular density, perfusion density, foveal avascular zone, optical coherence tomography angiography, macular ischemiaDabir SRajan MParasseril LBhatt VSamant PWebers CBerendschot TTJMDove Medical Pressarticlediabetic macular oedemasuperficial capillary plexusvascular densityperfusion densityfoveal avascular zoneoptical coherence tomography angiographymacular ischemiaOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 15, Pp 331-339 (2021)
institution DOAJ
collection DOAJ
language EN
topic diabetic macular oedema
superficial capillary plexus
vascular density
perfusion density
foveal avascular zone
optical coherence tomography angiography
macular ischemia
Ophthalmology
RE1-994
spellingShingle diabetic macular oedema
superficial capillary plexus
vascular density
perfusion density
foveal avascular zone
optical coherence tomography angiography
macular ischemia
Ophthalmology
RE1-994
Dabir S
Rajan M
Parasseril L
Bhatt V
Samant P
Webers C
Berendschot TTJM
Early Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography
description Supriya Dabir,1 Mohan Rajan,1 Liji Parasseril,1 Vaidehi Bhatt,2 Preetam Samant,3 CAB Webers,4 TTJM Berendschot4 1Department of Retina, Rajan Eye Care Pvt Ltd, Chennai, India; 2Rajiv Gandhi Medical College, Thane, India; 3Department of Retina, PD Hinduja Hospital and Medical Research Center, Mumbai, India; 4University Eye Clinic, Maastricht, the NetherlandsCorrespondence: Supriya DabirRajan Eye Care Hospital Pvt. Ltd, No. 5, Vidyodaya East 2nd Street, T. Nagar, Chennai, Tamil Nadu 600017, IndiaTel +919900974800Email supriad@gmail.comPurpose: Diabetic macular oedema (DME) is a vision-threatening complication of diabetic retinopathy. Spectral domain optical coherence tomography angiography (OCTA) is useful for assessing DME. We performed serial OCTA measurements before and after 3 monthly intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections to understand its relationship with best corrected visual acuity (BCVA), central macular thickness (CMT) and vascular indices.Methods: OCTA assessment consisting of 6 × 6 mm scans centred on fovea and en-face retinal angiograms were obtained. Scans were done at baseline and at 1 month following each of the 3 intravitreal injections of anti-VEGF (ranibizumab, Lucentis®).Results: Our prospective study included 24 eyes of 24 subjects, aged 63.0 ± 5.0 years. There was a mean gain of 0.07 LogMAR (3 letters) and reduction of CMT, vessel density (VD) and perfusion density (PD) by end of 3rd month. CMT was independently associated with improvement in BCVA. There were significant reductions in FAZ area, VD and PD over 3 months from baseline.Conclusion: At three months, intravitreal anti-VEGF therapy is associated with visual function recovery in DME, with reduction in CMT being the most reliable predictor of response. OCTA shows a reduction in VD and PD respectively suggestive of reduced macular perfusion in the short term. Simultaneous reduction in FAZ size can be due to reversal of manual displacement of the retinal capillaries resulting from resolution of intraretinal oedema.Keywords: diabetic macular oedema, superficial capillary plexus, vascular density, perfusion density, foveal avascular zone, optical coherence tomography angiography, macular ischemia
format article
author Dabir S
Rajan M
Parasseril L
Bhatt V
Samant P
Webers C
Berendschot TTJM
author_facet Dabir S
Rajan M
Parasseril L
Bhatt V
Samant P
Webers C
Berendschot TTJM
author_sort Dabir S
title Early Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography
title_short Early Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography
title_full Early Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography
title_fullStr Early Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography
title_full_unstemmed Early Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography
title_sort early visual functional outcomes and morphological responses to anti-vascular growth factor therapy in diabetic macular oedema using optical coherence tomography angiography
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/a089ed50f09e4a5489183b9ab9d6ad92
work_keys_str_mv AT dabirs earlyvisualfunctionaloutcomesandmorphologicalresponsestoantivasculargrowthfactortherapyindiabeticmacularoedemausingopticalcoherencetomographyangiography
AT rajanm earlyvisualfunctionaloutcomesandmorphologicalresponsestoantivasculargrowthfactortherapyindiabeticmacularoedemausingopticalcoherencetomographyangiography
AT parasserill earlyvisualfunctionaloutcomesandmorphologicalresponsestoantivasculargrowthfactortherapyindiabeticmacularoedemausingopticalcoherencetomographyangiography
AT bhattv earlyvisualfunctionaloutcomesandmorphologicalresponsestoantivasculargrowthfactortherapyindiabeticmacularoedemausingopticalcoherencetomographyangiography
AT samantp earlyvisualfunctionaloutcomesandmorphologicalresponsestoantivasculargrowthfactortherapyindiabeticmacularoedemausingopticalcoherencetomographyangiography
AT webersc earlyvisualfunctionaloutcomesandmorphologicalresponsestoantivasculargrowthfactortherapyindiabeticmacularoedemausingopticalcoherencetomographyangiography
AT berendschotttjm earlyvisualfunctionaloutcomesandmorphologicalresponsestoantivasculargrowthfactortherapyindiabeticmacularoedemausingopticalcoherencetomographyangiography
_version_ 1718391922968494080